Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
N/A
-1,454,158 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
N/A
1,331,388 Added 1084.46%
1,454,158 $0
Q1 2021

May 17, 2021

BUY
N/A
40,661 Added 49.52%
122,770 $158,000
Q4 2020

Feb 16, 2021

SELL
N/A
-1,968,934 Reduced 96.0%
82,109 $80,000
Q3 2020

Nov 16, 2020

BUY
N/A
2,051,043 New
2,051,043 $3.08 Million
Q2 2020

Aug 14, 2020

SELL
N/A
-16,038 Closed
0 $0
Q1 2020

May 15, 2020

BUY
N/A
16,038 New
16,038 $9,000
Q4 2019

Feb 14, 2020

SELL
N/A
-21,337 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
N/A
21,337 New
21,337 $0

About Aerpio Pharmaceuticals, Inc.


  • Ticker ARPO
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,371,500
  • Market Cap $105M
More about ARPO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.